The observation that, after oral glucose administration, the anti-lipolytic and anti-proteolytic action of insulin is blunted in the context of matching plasma glucose levels and similar glucose Ra, and moreover that glucose MCR/I is reduced, points to the development of insulin resistance when glucose is given orally. The gene discussed is INS; the disease is Insulin resistance.